I'm curious about whether SAS Viya reports are being accepted by the USFDA for regulatory submission, similar to how the industry currently uses SAS 9.4. Can you provide some insights on this?
Viya compute is fully backward compatible to SAS9.4 meaning you can in principle run the exactly same code and though I wouldn't know why using a different SAS version should create issues.